Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
$174.13 USD
Updated Jul 19 12:00am
Add VRTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
VRTX News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesVertex Pharmaceuticals Incorporated (VRTX) Company Bio
Vertex Pharmaceuticals engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF); and advancing its research and early-stage development programs. The company was founded in 1989 and is based in Boston, Massachusetts.
VRTX Stock Chart More Charts
VRTX Price/Volume Stats
| Current price | $174.13 |
| Prev. close | $178.09 |
| Day low | $174.04 |
| Day high | $179.15 |
| 50-day MA | $174.03 |
| 200-day MA | $177.48 |
| 52-week high | $195.81 |
| 52-week low | $151.80 |
| Volume | 1,121,600 |
| Avg. volume | 1,299,072 |
| Dividend yield | N/A |
| Market Cap | 44.60B |
VRTX Returns
| 1-mo | -5.35% |
| 3-mo | 3.33% |
| 6-mo | -10.19% |
| 1-year | -1.84% |
| 3-year | 86.81% |
| 5-year | 78.16% |
| YTD | 5.08% |
| 2018 | 10.58% |
| 2017 | 103.42% |
| 2016 | -41.45% |
| 2015 | 5.92% |
| 2014 | 59.89% |
Loading social stream, please wait...